IP Library Granted Patent US 10,022,252
Granted Patent B2
US 10,022,252 · App. 15/012,274 · Granted Jul 17, 2018

Spiral blood flow device with diameter independent helix angle

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,022,252
App. No.
15/012,274
Granted
Jul 17, 2018
Kind
B2
Abstract

A spiral blood flow device includes a stent made up of a plurality of expansion members joined to a plurality of axial members that permit the stent to change diameter among a continuum of expanded configurations. The axial members have fixed orientation, whereas the expansion members have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations. A spiral flow inducing structure, which may include fins attached to the axial members, define a helical flow angle that remains constant throughout the continuum of expanded configurations.

Claims (32)

1. A spiral blood flow device comprising:

a stent having a longitudinal axis and being movable among a transport configuration and a continuum of expanded configurations;

the stent including a plurality of expansion members joined to a plurality of axial members, and wherein each of the axial members have a fixed orientation relative to the longitudinal axis throughout the continuum of expanded configurations, and the expansion members each have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations;

a spiral flow inducing structure attached to each of the plurality of axial members defining a helical flow angle relative to the longitudinal axis; and

the helical flow angle being a constant throughout the continuum of expanded configurations.

2. The spiral blood flow device of claim 1 wherein each of the spiral flow inducing structures includes a fin attached at one edge to a respective one of the plurality of axial members.

3. The spiral blood flow device of claim 2 wherein each of the fins is identically shaped.

4. The spiral blood flow device of claim 3 wherein each of the fins is attached at exactly one attachment to the respective one of the plurality of axial members.

5. The spiral blood flow device of claim 1 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis throughout the continuum of expanded configurations.

6. The spiral blood flow device of claim 5 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis in the transport configuration.

7. The spiral blood flow device of claim 6 wherein each of the spiral flow inducing structures includes a fin attached at one edge to a respective one of the plurality of axial members.

8. The spiral blood flow device of claim 7 wherein each of the fins is identically shaped.

9. The spiral blood flow device of claim 1 wherein each of the plurality of axial members is attached at opposite ends to vertices that change shape throughout the continuum of expanded configurations.

10. The spiral blood flow device of claim 1 wherein each of the plurality of axial members has a vessel contact surface radially remote from the longitudinal axis.

11. The spiral blood flow device of claim 1 wherein the stent is a self expanding stent.

12. The spiral blood flow device of claim 11 wherein a diameter of the self expanding stent ranges from 2 mm to 6 mm over the continuum of expanded configurations.

13. The spiral blood flow device of claim 1 wherein each of the plurality of axial members is orientated parallel to the longitudinal axis in the transport configuration and throughout the continuum of expanded configurations;

wherein each of the plurality of axial members is attached at opposite ends to vertices that change shape throughout the continuum of expanded configurations, and each of the plurality of axial members has a vessel contact surface radially remote from the longitudinal axis;

wherein each of the spiral flow inducing structures includes a fin attached at one edge to a respective one of the plurality of axial members, and each of the fins is identically shaped; and

wherein the stent is a self expanding stent.

14. A method of impeding neointimal hyperplasia with a spiral blood flow device that includes a stent having a longitudinal axis and being movable among a transport configuration and a continuum of expanded configurations; the stent including a plurality of expansion members joined to a plurality of axial members, and wherein each of the axial members have a fixed orientation relative to the longitudinal axis throughout the continuum of expanded configurations, and the expansion members each have a variable orientation relative to the longitudinal axis throughout the continuum of expanded configurations; a spiral flow inducing structure attached to each of the plurality of axial members defining a helical flow angle relative to the longitudinal axis; and the helical flow angle being a constant throughout the continuum of expanded configurations, and the method comprising the steps of:

moving the spiral blood flow device in the transport configuration to an implantation site;

implanting the spiral blood flow device at the implantation site at least in part by expanding the stent to a first diameter in the continuum of expanded configurations;

inducing spiral flow in blood flowing through the spiral blood flow device with the spiral flow inducing structure;

changing the spiral blood flow device from the first diameter to a second diameter in the continuum of expanded configurations responsive to a vessel diameter increase at the implantation site; and

maintaining the helical flow angle constant throughout the change from the first diameter to the second diameter.

15. The method of claim 14 wherein the implanting step includes releasing the spiral blood flow device to self expand at the implantation site.

16. The method of claim 15 wherein the implanting step includes moving the plurality of axial members of the stent into contact with a vessel wall, and deploying a plurality of fins of the spiral flow inducing structure to define the helical flow angle.

17. The method of claim 16 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis throughout the change from the first diameter to the second diameter.

18. The method of claim 17 wherein each of the plurality of axial members is oriented parallel to the longitudinal axis in the transport configuration.

19. The method of claim 18 wherein each of the plurality of axial members is attached at opposite ends to vertices that change shape during the implanting step and during the change from the first diameter to the second diameter.

20. The method of claim 19 wherein the continuum of expanded configurations corresponds to a diameter of the stent ranging from 2 mm to 6 mm.

Assignments (1)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
Cited By (3)
US 12,208,002 US 12,343,249 US 12,551,329